Home > News > Altair Nanotechnologies to Present at the Wall Street Analyst Forum
February 25th, 2004
Altair Nanotechnologies to Present at the Wall Street Analyst Forum
Altair Nanotechnologies Inc. announced today that its President, Dr. Rudi Moerck, will be presenting to members of the financial community at the Wall Street Analyst Forum's Pharmaceutical Conference in New York City on March 1, 2004. Dr. Moerck will provide an overview of Altair Nanotechnologies' technology platform along with an in depth discussion and update of the company's patent-pending pharmaceutical, RenaZorb™. Additionally, Dr. Moerck will discuss the company's new nano-based drug delivery system that may possess properties that reduce the potential for the abuse of narcotics.
Wyatt Technology’s 24th International Light Scattering Colloquium to Highlight Developments in Applications and Characterization of Nanoparticles August 21st, 2014
Ultra-short pulse lasers & Positioning August 21st, 2014
Malvern’s Dr Alan Rawle talks TLAs in plenary lecture at Particulate Systems Analysis conference August 21st, 2014
Water window imaging opportunity: A new theoretical study elucidates mechanisms that could help in producing coherent radiations, ultimately promoting high-contrast imaging of biological samples August 21st, 2014